Author:
Wu Songjie,Zhu Shanhui,Yan Xumeng,Xu Yongshi,Xu Huifang,Yang Fang,Han Zhigang,Gu Yuzhou,Zhou Yi,Yang Zhengrong,Yang Huake,Shu Bo,Tang Weiming,Liang Ke
Abstract
Abstract
Background
People living with HIV(PLWH) are deemed more vulnerable to the SARS-CoV-2 infection than the uninfected population. Vaccination is an effective measure for COVID-19 control, yet, little knowledge exists about the willingness of men who have sex with men (MSM) living with HIV in China to be vaccinated.
Methods
This cross-sectional study evaluated the willingness of MSM living with HIV to receive COVID-19 vaccination in six cities of Guangdong, China, from July to September 2020. Factors associated with willingness to receive COVID-19 vaccination using multivariable logistic regression.
Results
In total, we recruited 944 HIV-positive MSM with a mean age of 29.2 ± 7.7 years. Of all participants, 92.4% of them were willing to receive the COVID-19 vaccine. Participants who were separated, divorced, or widowed (adjusted OR: 5.29, 95%CI: 1.02–27.48), had an annual income higher than 9,000 USD (adjusted OR: 1.70, 95%CI: 1.01–2.86), had ever taken an HIV self-test (adjusted OR: 1.78, 95%CI: 1.07–2.95), had ever disclosed sexual orientation to a doctor/nurse (adjusted OR: 3.16, 95%CI: 1.33–7.50), had ever disclosed sexual orientation to others besides their male partners (adjusted OR: 2.18, 95%CI: 1.29–3.69) were more willing to receive the vaccine. Sex with a female partner in the past six months decreased the likelihood of willingness to receive the vaccine (adjusted OR: 0.40, 95%CI: 0.17–0.95). Economic burden, worry that my health condition could not bear the risk of receiving COVID-19 vaccines, and concern that the vaccination would affect the immune status and antiretroviral therapy were the main reasons for unwillingness to receive vaccination.
Conclusion
Our study showed that HIV-positive MSM had a high willingness to receive the COVID-19 vaccination. Targeted interventions such as health education should be conducted among MSM with HIV infection to enhance COVID-19 vaccine uptake.
Funder
the National Nature Science Foundation of China
NIMH
the National Science and Technology Major Project
Special Found on Prevention and Control of New Coronary Pneumonia in Guangdong Universities
National Key Research and Development Program of China
Medical Science and Technology Innovation Platform Support Project of Zhongnan Hospital, Wuhan University
The Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
Science and Technology Innovation Cultivation Fund of Zhongnan Hospital, Wuhan University
Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference43 articles.
1. Kim SY, Yeniova AÖ. Global, regional, and national incidence and mortality of COVID-19 in 237 countries and territories, January 2022: a systematic analysis for World Health Organization COVID-19 Dashboard. Life Cycle. 2022;2:e10.
2. Lee KW, Yap SF, Ngeow YF, Lye MS. COVID-19 in people living with HIV: a systematic review and meta-analysis. Int J Environ Res Public Health. 2021;18(7):3554.
3. Shiau S, Krause KD, Valera P, Swaminathan S, Halkitis PN. The Burden of COVID-19 in People Living with HIV: a syndemic perspective. AIDS Behav. 2020;24(8):2244–9.
4. Centers for Disease Control and Prevention. Selected National HIV Prevention and Care Outcomes. 2019. https://www.cdc.gov/hiv/ppt/library/slidesets/cdc-hiv-prevention-and-care-outcomes-2016.pptx. Accessed 04 Dec 2020.
5. Heslin KC, Hall JE. Sexual orientation disparities in risk factors for adverse COVID-19-related outcomes, by race/ethnicity - behavioral risk factor surveillance system, United States, 2017–2019. MMWR Morb Mortal Wkly Rep. 2021;70(5):149–54.